We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.74B
AUM Growth
+$276M
(+19%)
Cap. Flow
+$178M
Cap. Flow
% of AUM
10.22%
Top 10 Holdings %
Top 10 Hldgs %
26.57%
Holding
376
New
39
Increased
143
Reduced
134
Closed
9
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Equity ETF
DFUS
|
+$53.3M |
| 2 |
U.S. Targeted Value Portfolio ETF Class Shares
DFAT
|
+$48.6M |
| 3 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$28.7M |
| 4 |
U.S. Small Cap Portfolio ETF Class Shares
DFAS
|
+$28.3M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.93M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$1.82M |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
| 4 |
The Marzetti Company
MZTI
|
+$1.18M |
| 5 |
iShares Micro-Cap ETF
IWC
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 31.47% |
| 2 | Technology | 15.8% |
| 3 | Financials | 10.71% |
| 4 | Healthcare | 10.19% |
| 5 | Consumer Staples | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Truist Financial
TFC
$56.9B
| $789K | 0.05% |
14,223
-384
| -3% | -$22.6K |
2019 Q2
8 quarters
|
|
227
iShares TIPS Bond ETF
TIP
$14.4B
| $784K | 0.05% |
6,124
-358
| -6% | -$45.5K |
2017 Q4
14 quarters
|
|
228
Strategy Inc
MSTR
$64.1B
| $781K | 0.04% |
+11,750
| New | +$695K |
2021 Q2
0 quarters
|
|
229
Gossamer Bio
GOSS
$54.4M
| $776K | 0.04% |
1,195
-375
| -24% | -$260K |
2020 Q3
3 quarters
|
|
230
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.2B
| $775K | 0.04% |
2,248
| – | – |
2013 Q2
32 quarters
|
|
231
iShares MSCI ACWI ETF
ACWI
$32.9B
| $763K | 0.04% |
7,538
| – | – |
2016 Q2
20 quarters
|
|
232
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $715K | 0.04% |
7,523
| – | – |
2019 Q3
7 quarters
|
|
233
Western Alliance Bancorporation
WAL
$8.11B
| $696K | 0.04% |
7,492
| – | – |
2013 Q4
30 quarters
|
|
234
iShares MSCI USA Momentum Factor ETF
MTUM
$19.1B
| $690K | 0.04% |
3,976
| – | – |
2020 Q2
4 quarters
|
|
235
Norfolk Southern
NSC
$73B
| $687K | 0.04% |
2,588
+367
| +17% | +$101K |
2016 Q4
18 quarters
|
|
236
Archer Daniels Midland
ADM
$40B
| $659K | 0.04% |
10,874
-295
| -3% | -$18.7K |
2019 Q2
8 quarters
|
|
237
Dell
DELL
$301B
| $655K | 0.04% |
12,961
-45
| -0.3% | -$2.26K |
2019 Q1
9 quarters
|
|
238
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $651K | 0.04% |
4,320
| – | – |
2017 Q3
15 quarters
|
|
239
SPDR Gold Trust
GLD
$142B
| $646K | 0.04% |
3,900
| – | – |
2020 Q1
5 quarters
|
|
240
SLB Ltd
SLB
$71.8B
| $646K | 0.04% |
20,172
-950
| -4% | -$29.2K |
2013 Q2
32 quarters
|
|
241
Fortive
FTV
$17.5B
| $637K | 0.04% |
12,114
| – | – |
2016 Q3
19 quarters
|
|
242
iShares Select Dividend ETF
DVY
$23B
| $636K | 0.04% |
5,454
-12
| -0.2% | -$1.43K |
2014 Q1
29 quarters
|
|
243
CACI
CACI
$13.5B
| $635K | 0.04% |
2,490
| – | – |
2017 Q1
17 quarters
|
|
244
Shopify
SHOP
$229B
| $631K | 0.04% |
4,320
+130
| +3% | +$16K |
2020 Q2
4 quarters
|
|
245
Hewlett Packard
HPE
$77.8B
| $628K | 0.04% |
43,086
-1,845
| -4% | -$29.1K |
2015 Q4
22 quarters
|
|
246
ResMed
RMD
$34.1B
| $608K | 0.03% |
2,467
| – | – |
2017 Q4
14 quarters
|
|
247
State Street
STT
$46B
| $607K | 0.03% |
7,378
-847
| -10% | -$71.5K |
2013 Q2
32 quarters
|
|
248
Fox Class A
FOXA
$27B
| $605K | 0.03% |
16,300
-1,103
| -6% | -$41.4K |
2019 Q1
9 quarters
|
|
249
iShares Core MSCI EAFE ETF
IEFA
$190B
| $604K | 0.03% |
8,064
+840
| +12% | +$63.4K |
2020 Q4
2 quarters
|
|
250
T-Mobile US
TMUS
$168B
| $598K | 0.03% |
4,132
+2,050
| +98% | +$283K |
2021 Q1
1 quarter
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q2 2021 Portfolio in Review
As of Q2 2021, Dowling & Yahnke held 376 positions worth $1.74B, up 19% from $1.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Dowling & Yahnke deployed $178M of net new capital in Q2 2021, opening 39 new positions and adding to 143 existing holdings. Its largest new stake was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Bank of America, an estimated $1.93M trimmed.
- Dowling & Yahnke's largest Q2 2021 buy was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.
- Dowling & Yahnke added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $5.26M increase.
- Dowling & Yahnke's biggest Q2 2021 reduction was Bank of America, cutting an estimated $1.93M.
- Dowling & Yahnke fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $1.82M.
- Dowling & Yahnke's ten largest holdings make up 27% of its $1.74B portfolio in Q2 2021.
- Dowling & Yahnke opened 39 new positions and closed 9 in Q2 2021.
- Dowling & Yahnke's portfolio value rose 19% quarter-over-quarter to $1.74B.
Based on Dowling & Yahnke's 13F filing for Q2 2021, filed 21 Jul 2021.